Stock APRE APREA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Aprea Therapeutics, Inc.

Equities

APRE

US03836J2015

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
4.77 USD +3.54% Intraday chart for Aprea Therapeutics, Inc. -9.98% +1.49%
May. 28 Aprea Therapeutics, Inc. Announces Safety Review Committee Endorses Dosing of Patients with ATRN-119 at 800 Mg Once Daily in Ongoing ABOYA-119 Clinical Trial CI
May. 14 Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APRE Stock
  4. News Aprea Therapeutics, Inc.
  5. MarketScreener Strategies